Investigating the association between allergic diseases and COVID-19 in 400 Iranian patients

Amirhossein Darabi1, Mohammadrezad Dehghanfard2, Sara Jozan3

  • 1Department of Epidemiology, The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.

Insights

Allergic diseases, particularly allergic rhinitis (AR), were not a risk factor for severe COVID-19. Patients with AR experienced milder COVID-19 symptoms and less severe outcomes compared to those without allergies.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Allergy and Clinical Immunology

Background:

  • Allergic diseases are common and may influence susceptibility to infections.
  • The role of allergic comorbidity in coronavirus disease 2019 (COVID-19) severity remains unclear.
  • Investigating the association between allergies and COVID-19 outcomes is crucial for understanding disease pathogenesis.

Purpose of the Study:

  • To determine if allergic diseases predispose individuals to COVID-19.
  • To assess the association between allergic comorbidity and COVID-19 severity.
  • To analyze the clinical manifestations and outcomes of COVID-19 in patients with and without allergic diseases.

Main Methods:

  • A cohort of 400 COVID-19 patients was analyzed.
  • Allergic diseases were identified using the standard GA²LEN questionnaire.
  • COVID-19 severity was assessed using a visual analog scale (VAS) and intensive care unit (ICU) admission data.

Main Results:

  • 39.5% of COVID-19 patients had allergic diseases, showing a reverse association with disease severity (P=0.005).
  • Allergic rhinitis (AR) was significantly associated with milder COVID-19 (P=0.02).
  • Allergic patients had lower rates of hypoxemia and chest CT involvement compared to non-allergic patients (P=0.002 and P=0.003, respectively).

Conclusions:

  • Allergic diseases do not predispose individuals to severe COVID-19.
  • Allergic rhinitis is linked to milder clinical manifestations and reduced ICU admission in COVID-19 patients.
  • Allergies may have a protective effect against severe outcomes in COVID-19.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
846
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.3K
Allergic Reactions02:06

Allergic Reactions

Overview
29.3K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.1K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.7K